029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
FOV2086卵巢肿瘤普查组织芯片(5之2),附病理分级、TNM和临床分期,104例/208点
点 数208例 数104
行 数13列 数16
点直径(mm)1.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:FOV2086
 
卵巢肿瘤普查组织微阵列芯片(520例卵巢肿瘤普查系列之2),含104例恶性肿瘤(浆液性腺癌44例,子宫内膜样腺癌8例,粘液性腺癌15例,颗粒细胞瘤10例,颗粒-卵泡膜细胞瘤及卵泡膜细胞瘤各3例,内胚窦癌5例,鳞状细胞癌2例,未分化癌、透明细胞癌及移行细胞癌各1例,支持细胞瘤2例,支持-间质细胞瘤1例,无性细胞瘤2例,混合性生殖细胞瘤及两性母细胞瘤各1例,未成熟畸胎瘤2例,纤维肉瘤及类固醇细胞瘤各1例),+一例两点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Ova
-Ovary
 
Malignant (I)
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (IC)
 
Malignant (II)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (IIC)
 
Malignant (III)
 
Malignant (IIIB)
 
Malignant (IIIC)
 
Malignant (IV)
TISSUE  ARRAYS FOV2086
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
A
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
B
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
C
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
D
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
E
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
F
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
G
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
H
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
I
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
J
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
K
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
L
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
M
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeisBackUp
A1150FOvarySerous papillary adenocarcinoma1T2aN0M0IIAMalignantN
A2250FOvarySerous papillary adenocarcinoma1T2aN0M0IIAMalignantN
A3345FOvarySerous adenocarcinoma1T1aN0M0IAMalignantN
A4445FOvarySerous adenocarcinoma1T1aN0M0IAMalignantN
A5558FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignantN
A6658FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignantN
A7734FOvarySerous papillary adenocarcinoma1T1aN0M0IAMalignantN
A8834FOvarySerous papillary adenocarcinoma1T1aN0M0IAMalignantN
A9953FOvarySerous adenocarcinoma with necrosis2T1aN0M0IAMalignantN
A101053FOvarySerous adenocarcinoma with necrosis2T1aN0M0IAMalignantN
A111140FOvarySerous papillary adenocarcinoma (sparse)1T2aN0M0IIAMalignantN
A121240FOvarySerous papillary adenocarcinoma1T2aN0M0IIAMalignantN
A131326FOvarySerous adenocarcinoma1T1cN0M0ICMalignantN
A141426FOvarySerous adenocarcinoma1T1cN0M0ICMalignantN
A151560FOvarySerous papillary adenocarcinoma1T1bN0M0IBMalignantN
A161660FOvarySerous papillary adenocarcinoma1T1bN0M0IBMalignantN
B11745FOvarySerous adenocarcinoma2T2N1M0IIICMalignantN
B21845FOvarySerous adenocarcinoma2T2N1M0IIICMalignantN
B31953FOvarySerous papillary adenocarcinoma2T1N0M0IMalignantN
B42053FOvarySerous papillary adenocarcinoma2T1N0M0IMalignantN
B52161FOvarySerous papillary adenocarcinoma2T1bN0M0IBMalignantN
B62261FOvarySerous papillary adenocarcinoma2T1bN0M0IBMalignantN
B72359FOvarySerous adenocarcinoma3T1cN0M0ICMalignantN
B82459FOvarySerous adenocarcinoma3T1cN0M0ICMalignantN
B92527FOvarySerous papillary adenocarcinoma2T2bN0M0IIBMalignantN
B102627FOvarySerous papillary adenocarcinoma2T2bN0M0IIBMalignantN
B112754FOvarySerous adenocarcinoma1T1bN0M0IBMalignantN
B122854FOvarySerous adenocarcinoma1T1bN0M0IBMalignantN
B132964FOvarySerous papillary adenocarcinoma3T3N1M1IVMalignantN
B143064FOvarySerous papillary adenocarcinoma3T3N1M1IVMalignantN
B153152FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignantN
B163252FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignantN
C13358FOvarySerous papillary adenocarcinoma2T2bN0M0IIBMalignantN
C23458FOvarySerous papillary adenocarcinoma2T2bN0M0IIBMalignantN
C33551FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignantN
C43651FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignantN
C53766FOvarySerous papillary adenocarcinoma2T1cN0M0ICMalignantN
C63866FOvarySerous papillary adenocarcinoma2T1cN0M0ICMalignantN
C73947FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignantN
C84047FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignantN
C94157FOvarySerous papillary adenocarcinoma3T2aN0M0IIAMalignantN
C104257FOvarySerous papillary adenocarcinoma3T2aN0M0IIAMalignantN
C114348FOvarySerous adenocarcinoma2T1aN0M0IAMalignantN
C124448FOvarySerous adenocarcinoma2T1aN0M0IAMalignantN
C134563FOvarySerous papillary adenocarcinoma2T1bN0M0IBMalignantN
C144663FOvarySerous papillary adenocarcinoma2T1bN0M0IBMalignantN
C154737FOvarySerous adenocarcinoma (sparse) with necrosis2T1bN0M0IBMalignantN
C164837FOvarySerous adenocarcinoma with necrosis2T1bN0M0IBMalignantN
D14958FOvarySerous adenocarcinoma3T3cN1M0IVMalignantN
D25058FOvarySerous adenocarcinoma3T3cN1M0IVMalignantN
D35168FOvarySerous adenocarcinoma with necrosis2T1aN0M0IAMalignantN
D45268FOvarySerous adenocarcinoma with necrosis2T1aN0M0IAMalignantN
D55350FOvarySerous adenocarcinoma3T1bN0M0IBMalignantN
D65450FOvarySerous adenocarcinoma with necrosis3T1bN0M0IBMalignantN
D75536FOvarySerous adenocarcinoma3T1bN0M0IBMalignantN
D85636FOvarySerous adenocarcinoma3T1bN0M0IBMalignantN
D95754FOvarySerous adenocarcinoma2T1bN0M0IBMalignantN
D105854FOvarySerous adenocarcinoma2T1bN0M0IBMalignantN
D115958FOvarySerous adenocarcinoma with necrosis2T1N0M0IMalignantN
D126058FOvarySerous adenocarcinoma with necrosis2T1N0M0IMalignantN
D136141FOvarySerous papillary adenocarcinoma2T1N0M0IMalignantN
D146241FOvarySerous papillary adenocarcinoma2T1N0M0IMalignantN
D156357FOvarySerous papillary adenocarcinoma2T2bN0M0IIBMalignantN
D166457FOvarySerous papillary adenocarcinoma2T2bN0M0IIBMalignantN
E16550FOvarySerous adenocarcinoma3T3bN1M0IIICMalignantN
E26650FOvarySerous adenocarcinoma3T3bN1M0IIICMalignantN
E36759FOvarySerous adenocarcinoma2T2bN0M0IIBMalignantN
E46859FOvarySerous adenocarcinoma2T2bN0M0IIBMalignantN
E56944FOvarySerous adenocarcinoma2T2aN0M0IIAMalignantN
E67044FOvarySerous adenocarcinoma2T2aN0M0IIAMalignantN
E77153FOvarySerous adenocarcinoma2T2aN0M0IIAMalignantN
E87253FOvarySerous adenocarcinoma2T2aN0M0IIAMalignantN
E97352FOvarySerous adenocarcinoma (sparse) with necrosis3T2N0M0IIMalignantN
E107452FOvarySerous adenocarcinoma with necrosis3T2N0M0IIMalignantN
E117552FOvarySerous adenocarcinoma3T1cN0M0ICMalignantN
E127652FOvarySerous adenocarcinoma3T1cN0M0ICMalignantN
E137741FOvarySerous adenocarcinoma3T1aN0M0IAMalignantN
E147841FOvarySerous adenocarcinoma3T1aN0M0IAMalignantN
E157960FOvarySerous adenocarcinoma3T1aN0M0IAMalignantN
E168060FOvarySerous adenocarcinoma3T1aN0M0IAMalignantN
F18151FOvarySerous adenocarcinoma3T1cN0M0ICMalignantN
F28251FOvarySerous adenocarcinoma3T1cN0M0ICMalignantN
F38370FOvarySerous adenocarcinoma3T1N0M0IMalignantN
F48470FOvarySerous adenocarcinoma3T1N0M0IMalignantN
F58548FOvarySerous adenocarcinoma3T2aN0M0IIAMalignantN
F68648FOvarySerous adenocarcinoma3T2aN0M0IIAMalignantN
F78762FOvarySerous adenocarcinoma3T1bN0M0IBMalignantN
F88862FOvarySerous adenocarcinoma3T1bN0M0IBMalignantN
F98947FOvaryEndometrioid adenocarcinoma1T2aN0M0IIAMalignantN
F109047FOvaryEndometrioid adenocarcinoma1T2aN0M0IIAMalignantN
F119149FOvaryEndometrioid adenocarcinoma with necrosis2T1N0M0IMalignantN
F129249FOvaryEndometrioid adenocarcinoma with necrosis2T1N0M0IMalignantN
F139343FOvaryEndometrioid adenocarcinoma2T1cN0M0ICMalignantN
F149443FOvaryEndometrioid adenocarcinoma2T1cN0M0ICMalignantN
F159551FOvaryEndometrioid adenocarcinoma1T1aN0M0IAMalignantN
F169651FOvaryEndometrioid adenocarcinoma1T1aN0M0IAMalignantN
G19741FOvaryEndometrioid adenocarcinoma (sparse)2T1aN0M0IAMalignantN
G29841FOvaryEndometrioid adenocarcinoma2T1aN0M0IAMalignantN
G39943FOvaryEndometrioid adenocarcinoma3T1aN0M0IAMalignantN
G410043FOvaryEndometrioid adenocarcinoma3T1aN0M0IAMalignantN
G510155FOvaryEndometrioid adenocarcinoma3T1N0M0IMalignantN
G610255FOvaryEndometrioid adenocarcinoma3T1N0M0IMalignantN
G710353FOvaryEndometrioid adenocarcinoma3T2aN0M0IIAMalignantN
G810453FOvaryEndometrioid adenocarcinoma3T2aN0M0IIAMalignantN
G910563FOvaryMucinous adenocarcinoma1T1aN0M0IAMalignantN
G1010663FOvaryMucinous adenocarcinoma1T1aN0M0IAMalignantN
G1110760FOvaryMucinous adenocarcinoma (necrotic tissue)*T1aN0M0IAMalignantN
G1210860FOvaryMucinous adenocarcinoma1T1aN0M0IAMalignantN
G1310940FOvaryMucinous adenocarcinoma1T1aN0M0IAMalignantN
G1411040FOvaryMucinous adenocarcinoma (fibrous tissue and blood vessel)*T1aN0M0IAMalignantN
G1511145FOvaryMucinous adenocarcinoma (necrotic tissue)*T1aN0M0IAMalignantN
G1611245FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignantN
H111346FOvaryMucinous adenocarcinoma1T1aN0M0IAMalignantN
H211446FOvaryMucinous adenocarcinoma1T1aN0M0IAMalignantN
H311548FOvaryMucinous adenocarcinoma1T1bN0M0IBMalignantN
H411648FOvaryMucinous adenocarcinoma1T1bN0M0IBMalignantN
H511749FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignantN
H611849FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignantN
H711965FOvaryMucinous papillary adenocarcinoma1T2aN0M0IIAMalignantN
H812065FOvaryMucinous papillary adenocarcinoma1T2aN0M0IIAMalignantN
H912167FOvaryMucinous adenocarcinoma (sparse)*T3bN0M0IIIBMalignantN
H1012267FOvaryMucinous adenocarcinoma2T3bN0M0IIIBMalignantN
H1112339FOvaryMucinous adenocarcinoma1T1aN0M0IAMalignantN
H1212439FOvaryMucinous adenocarcinoma1T1aN0M0IAMalignantN
H1312551FOvaryMucinous adenocarcinoma with necrosis2T1bN0M0IBMalignantN
H1412651FOvaryMucinous adenocarcinoma with necrosis2T1bN0M0IBMalignantN
H1512741FOvaryMucinous adenocarcinoma3T1bN0M0IBMalignantN
H1612841FOvaryMucinous adenocarcinoma3T1bN0M0IBMalignantN
I112948FOvaryMucinous adenocarcinoma3T2cN0M0IICMalignantN
I213048FOvaryMucinous adenocarcinoma3T2cN0M0IICMalignantN
I313160FOvaryMucinous adenocarcinoma3T1aN0M0IAMalignantN
I413260FOvaryMucinous adenocarcinoma3T1aN0M0IAMalignantN
I513329FOvaryMucinous adenocarcinoma3T3N0M0IIIMalignantN
I613429FOvaryMucinous adenocarcinoma3T3N0M0IIIMalignantN
I713560FOvaryAdult granulosa cell tumor*T1aN0M0IAMalignantN
I813660FOvaryAdult granulosa cell tumor*T1aN0M0IAMalignantN
I913733FOvaryAdult granulosa cell tumor*T1aN0M0IAMalignantN
I1013833FOvaryAdult granulosa cell tumor*T1aN0M0IAMalignantN
I1113931FOvaryAdult granulosa cell tumor*T1aN0M0IAMalignantN
I1214031FOvaryAdult granulosa cell tumor*T1aN0M0IAMalignantN
I1314151FOvaryAdult granulosa cell tumor*T1aN0M0IAMalignantN
I1414251FOvaryAdult granulosa cell tumor*T1aN0M0IAMalignantN
I1514354FOvaryAdult granulosa cell tumor*T1aN0M0IAMalignantN
I1614454FOvaryAdult granulosa cell tumor*T1aN0M0IAMalignantN
J114565FOvaryAdult granulosa cell tumor*T2aN0M0IIAMalignantN
J214665FOvaryAdult granulosa cell tumor*T2aN0M0IIAMalignantN
J314749FOvaryAdult granulosa cell tumor*T1bN0M0IBMalignantN
J414849FOvaryAdult granulosa cell tumor*T1bN0M0IBMalignantN
J514959FOvaryAdult granulosa cell tumor*T1N0M0IMalignantN
J615059FOvaryAdult granulosa cell tumor*T1N0M0IMalignantN
J715160FOvaryAdult granulosa cell tumor*T1N0M0IMalignantN
J815260FOvaryAdult granulosa cell tumor*T1N0M0IMalignantN
J915359FOvaryAdult granulosa cell tumor*T1bN0M0IBMalignantN
J1015459FOvaryAdult granulosa cell tumor*T1bN0M0IBMalignantN
J1115539FOvaryGranulosa-theca cell tumor*T1N0M0IMalignantN
J1215639FOvaryGranulosa-theca cell tumor*T1N0M0IMalignantN
J1315749FOvaryGranulosa-theca cell tumor*T1N0M0IMalignantN
J1415849FOvaryGranulosa-theca cell tumor*T1N0M0IMalignantN
J1515959FOvaryGranulosa-theca cell tumor*T1N0M0IMalignantN
J1616059FOvaryGranulosa-theca cell tumor*T1N0M0IMalignantN
K116150FOvaryTheca cell tumor*T1aN0M0IAMalignantN
K216250FOvaryTheca cell tumor*T1aN0M0IAMalignantN
K316348FOvaryTheca cell tumor*T3N0M0IIIMalignantN
K416448FOvaryTheca cell tumor*T3N0M0IIIMalignantN
K516544FOvaryTheca cell tumor*T1aN0M0IAMalignantN
K616644FOvaryTheca cell tumor*T1aN0M0IAMalignantN
K716715FOvaryEndodermal sinus carcinoma*T2aN0M0IIAMalignantN
K816815FOvaryEndodermal sinus carcinoma*T2aN0M0IIAMalignantN
K916926FOvaryEndodermal sinus carcinoma*T1aN0M0IAMalignantN
K1017026FOvaryEndodermal sinus carcinoma*T1aN0M0IAMalignantN
K1117120FOvaryEndodermal sinus carcinoma*T1aN0M0IAMalignantN
K1217220FOvaryEndodermal sinus carcinoma*T1aN0M0IAMalignantN
K1317314FOvaryEndodermal sinus carcinoma*T1cN0M0ICMalignantN
K1417414FOvaryEndodermal sinus carcinoma*T1cN0M0ICMalignantN
K1517532FOvaryEndodermal sinus carcinoma*T1cN0M1IVMalignantN
K1617632FOvaryEndodermal sinus carcinoma*T1cN0M1IVMalignantN
L117762FOvarySquamous cell carcinoma from malignant transformation of teratoma2T1N0M0IMalignantN
L217862FOvarySquamous cell carcinoma from malignant transformation of teratoma2T1N0M0IMalignantN
L317926FOvaryUndifferentiated carcinoma*T1aN0M0IAMalignantN
L418026FOvaryUndifferentiated carcinoma*T1aN0M0IAMalignantN
L518150FOvarySquamous cell carcinoma from malignant transformation of teratoma2T1aN0M0IAMalignantN
L618250FOvarySquamous cell carcinoma from malignant transformation of teratoma2T1aN0M0IAMalignantN
L718354FOvaryClear cell carcinoma*T2aN0M0IIAMalignantN
L818454FOvaryClear cell carcinoma*T2aN0M0IIAMalignantN
L918557FOvaryTransitional cell carcinoma2T1aN0M0IAMalignantN
L1018657FOvaryTransitional cell carcinoma2T1aN0M0IAMalignantN
L1118730FOvarySertoli cell tumor*T1aN0M0IAMalignantN
L1218830FOvarySertoli cell tumor*T1aN0M0IAMalignantN
L1318949FOvarySertoli cell tumor*T1cN0M0ICMalignantN
L1419049FOvarySertoli cell tumor*T1cN0M0ICMalignantN
L1519159FOvarySertoli-leydig cell tumor*T1N0M0IMalignantN
L1619259FOvarySertoli-leydig cell tumor*T1N0M0IMalignantN
M119372FOvaryDysgerminoma*T2aN0M0IIAMalignantN
M219472FOvaryDysgerminoma*T2aN0M0IIAMalignantN
M319519FOvaryDysgerminoma*T1aN0M0IAMalignantN
M419619FOvaryDysgerminoma*T1aN0M0IAMalignantN
M519713FOvaryMixed germ cell tumors*T1aN0M0IAMalignantN
M619813FOvaryMixed germ cell tumors*T1aN0M0IAMalignantN
M719914FOvaryGynandroblastoma*T1aN0M0IAMalignantN
M820014FOvaryGynandroblastoma*T1aN0M0IAMalignantN
M920116FOvaryImmature teratoma*T1aN0M0IAMalignantN
M1020216FOvaryImmature+teratoma+(sparse)*T1aN0M0IAMalignantN
M1120349FOvaryImmature teratoma (mature teratoma)*T1N0M0IMalignantN
M1220449FOvaryImmature teratoma (mature teratoma)*T1N0M0IMalignantN
M1320546FOvaryFibrosarcoma*T2N0M0IBMalignantN
M1420646FOvaryFibrosarcoma*T2N0M0IBMalignantN
M1520747FOvarySteroid cell tumor, not otherwise specified*T1aN0M0IAMalignantN
M1620847FOvarySteroid cell tumor, not otherwise specified*T1aN0M0IAMalignantN
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情